language_icon
EN
HI

Trident Lifeline Share price

TLL

255.35

8.65 (-3.28%)
Last updated on 15 May, 2026 | 14:20 IST
Today's High

274.00

Today's Low

255.00

52 Week Low

229.95

52 Week High

328.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Trident Lifeline Chart

Trident Lifeline Share Key Metrics

Volume
45000.00
Market Cap
311.47 CR
LTQ@LTP
600@255.35
ATP
261.14
Var Margin
53.5 %
Circuit Range
211.2-316.8
Delivery %
71.43 %
Value
1.18 CR
ASM/GSM
No
Market Lot
600

Summary

15 May, 2026 | 14:20 को, Trident Lifeline का शेयर प्राइस आज ₹255.35 पर है, जो दिन के लिए 8.65% की -3.28 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹255.00 और ₹274.00 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹229.95 से ₹328.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Trident Lifeline ने 45000 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹11798000 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹26114 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 600,25535 रही। यह स्टॉक ₹211.2-316.8 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹1.18 CR है। दिन के लिए डिलीवरी परसेंटेज 71.43% रही। इसके अतिरिक्त, Trident Lifeline वर्तमान में No फ्रेमवर्क के तहत आता है और 600 के मार्केट लॉट साइज़ में ट्रेड करता

Trident Lifeline Fundamentals

View More
P/E Ratio

16.7

P/B Ratio

3.43

Div. Yield

0

Sector P/E

66.86

Sector P/B

3.47

Sec. Div. Yield

0.56

Trident Lifeline Resistance and Support

Pivot 262.77

Resistance

First Resistance

267.24

Second Resistance

270.47

Third Resistance

274.94

Support

First Support

259.54

Second Support

255.07

Third Support

251.84

Trident Lifeline Shareholding Pattern

View More
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

62.85%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

7.24%

Domestic Institutional Investors

0.27%

Retail

29.64%

Others

0%

Total Promoters
MAR '26
62.85%

Trident Lifeline Corporate Actions

DateAgenda
2026-05-07Audited Results
2026-05-05Audited Results
2026-01-17Quarterly Results

Trident Lifeline News

Trident Lifeline Ltd - 543616 - Appointment Of Internal Auditor

Trident Lifeline announced robust financial performance for FY26. Consolidated revenue grew 48% YoY to Rs.129.02 crore, while consolidated net profit increased 84% YoY to Rs.19.32 crore. Standalone results also showed strong growth.
May 07 2026 19:05:00

Trident Lifeline Ltd - 543616 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 07, 2026

Trident Lifeline announced robust FY26 consolidated financial results. Revenue surged by 45.28% to ₹138.29 crores, and net profit increased by 62.08% to ₹19.04 crores YoY. The board also appointed DAC & Co. Chartered Accountants as the Internal Auditor for FY2026-27.
May 07 2026 18:05:00

Trident Lifeline Ltd - 543616 - Update on board meeting

Trident Lifeline's board meeting for approving its FY26 audited financial results has been rescheduled from May 5, 2026, to May 7, 2026. The meeting will consider both standalone and consolidated results.
May 04 2026 17:05:00

Trident Lifeline Ltd - 543616 - Board Meeting Intimation for Approval Of The Audited Financial Results (Standalone & Consolidated) Of The Company For The Half Year And Year Ended 31St March, 2026

Trident Lifeline announced that its Board of Directors will meet on May 5, 2026. The primary agenda is to consider and approve the audited financial results for the half year and full year ended March 31, 2026.
Apr 29 2026 19:04:00

Trident Lifeline Ltd - 543616 - Announcement under Regulation 30 (LODR)-Acquisition

Trident Lifeline's shareholding in its subsidiary, Trident Mediquip Limited (TML), decreased to 59.47% from 59.77%. This change occurred after TML completed a private placement of equity shares to other shareholders. TML operates in the Pharmaceuticals and Chemical Industry.
Apr 17 2026 17:04:00
Read More

About Trident Lifeline AboutThe

NSE : 0  
BSE : 543616  
ISIN : INE0MKA01014  

Our Company was originally incorporated as “Trident Lifeline Private Limited” as a Private Limited Company under the provisions of the Companies Act 1956 vide Certificate of Incorporation dated January 09 2014 issued by the Registrar of Companies Gujarat Dadra and Nagar Havelli. Subsequently our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on June 02 2022 and the name of our Company was changed to “Trident Lifeline Limited”. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated June 10 2022 was issued by the Registrar of Companies Ahmedabad. The Corporate Identification Number of our Company is U51909GJ2014PLC078227.Our promoters and directors have a combined experience of more than 19 years in the pharmaceutical products Bulk drugs. Driven by the passion for building an integrated pharmaceutical company backed by their experience our Promoters have been the pillars of our Company's growth and have built a strong value system for our Company. With their enriching experience and progressive thinking we aim to continue to grow in the pharmaceutical and bulk drugs industry.Our Company is engaged in the pharmaceutical business ethical marketing in domestic as well as inernational market. We are also engaged in distribution of pharmaceutical products through third party distribution network. We offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. We operate in India as well as African Latin American and East Indian Countries. We have our presence through registered products or products under registration in countries like Bolivia Cambodia Cameroon Chile Ghana Kenya Myanamar Nigeria Peru Sudan Tajikistan Uzbekistan Venuzela.We deal in Capsules Tablets Liquid Ointment Gel Ice Gel Mouthwash Paste Solution Suspension Drypowders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti Bacterial Anti Diarrheal Anti Fungal Anti Malerial Anti Diabetic Dental Cure Proton Pump Inhibitor Anti Protozol Anti Histamine Anti Hypertensive drugs Anti Lipidemic Drug Anti Parasitic Multivitamin Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS). Our product portfolio consists of 832 products as on May 31 2022. We operate under different brand names across the globe. As on May 31 2022 we have 267 products registered in total 8 countries. As on May 31 2022 total565 products are under process of registration in 11 countries which shall boost the growth of our company.MAJOR EVENTS2014Our Company was incorporated as a private limited company under the name “Trident Lifeline Private Limited” Limited2021Our Company had Certified its Quality Management System Under the Certificate ISO 9001:2015.

Read More

Trident Lifeline Management

NamePosition
Nikita SharmaCompany Secretary & Compliance Officer
Hardik Jigishkumar DesaiChairman
View More

Trident Lifeline FAQs

Trident Lifeline शेयर का खरीद मूल्य 255.35 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Trident Lifeline शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Trident Lifeline शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 16.7 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Trident Lifeline शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.43 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Trident Lifeline शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.47 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Trident Lifeline का मार्केट कैप 311.47 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Trident Lifeline शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 328.00 और 229.95 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost